Clinical Trial Update: Autologous Vaccine for Follicular Lymphoma [Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1 study of an autologous vaccine for follicular lymphoma sponsored by Icon Genetics GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Autologous vaccine for Follicular lymphoma

Snippet

Sponsor: Icon Genetics GmbH | Conditions: Lymphoma, Follicular | Phase 1 | Status: COMPLETED